文献速递关节外科创伤骨科

全髋关节置换术后即刻使用唑吡坦增加跌倒风险与植入物并发症率:一项回顾性病例对照分析

Immediate Postoperative Zolpidem Use Increases Risk of Falls and Implant Complication Rates Following Total Hip Arthroplasty: A Retrospective Case-Control Analysis.
PubMed 文献 · J Arthroplasty · 2023-08-09

基于2010至2020年全国保险理赔数据库的回顾性病例对照研究,将术后90天内处方唑吡坦的患者与催眠药初治患者按1:5匹配,比较90天医疗并发症、跌倒、脆性骨折、费用、再入院率及2年植入物并发症。唑吡坦组医疗并发症、跌倒、脆性骨折及脱位、机械性松动、假体周围骨折发生率均显著更高,医疗资源利用也显著更高。作者认为该发现可能影响骨科医生与患者关于睡眠质量获益与唑吡坦风险的讨论。

要点

  • 全髋关节置换术后90天内使用唑吡坦与医疗并发症、跌倒、脆性骨折风险显著升高相关。
  • 唑吡坦组脱位、机械性松动、假体周围骨折等植入物并发症发生率显著更高。
  • 唑吡坦组医疗资源利用(费用、住院时长、再入院)显著更高。

核心结论

  • 全髋关节置换术后使用唑吡坦与医疗并发症、植入物并发症、跌倒风险、费用增加、住院时长延长及再入院显著相关。
  • 作者认为该研究结果可能影响骨科医生与患者关于睡眠质量在恢复中的获益与唑吡坦使用风险的讨论。

研究设计与样本

  • 回顾性查询2010至2020年全国保险理赔数据库,使用手术操作码与国家药品码识别全髋关节置换术及催眠药使用病例。
  • 术后90天内处方唑吡坦的患者与催眠药初治患者按人口学与合并症特征1:5匹配。
  • 共匹配50,328例唑吡坦患者与251,286例催眠药初治患者。
  • 比较两组90天医疗并发症、跌倒、脆性骨折、费用、再入院率及2年植入物并发症。
  • 证据等级III,为回顾性病例对照研究。

主要发现

  • 唑吡坦组医疗并发症、跌倒及脆性骨折发生率显著高于催眠药初治组。
  • 唑吡坦组脱位、机械性松动及假体周围骨折发生率显著更高。
  • 唑吡坦组医疗资源利用显著更高。

临床怎么用

  • 作者认为该研究结果可能影响骨科医生与患者关于睡眠质量在恢复中的获益与唑吡坦使用风险的讨论。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Zolpidem is the most widely used hypnotic in the United States and has known side effects. However, the morbidity of zolpidem use following total hip arthroplasty (THA) is not well-defined. Thus, the aim of this study was to assess the effects that zolpidem use has on medical and implant complications, falls, lengths of stay, and medical utilizations following THA. METHODS: A retrospective query of a nationwide insurance claims database was conducted from 2010 to 2020. All cases of THA and hypnotic use were identified using procedural and national drug codes. Patients who were prescribed zolpidem within 90 days of surgery were matched to hypnotic naive patients 1:5 based on demographic and comorbidity profiles. The 90-day medical complications, falls, fragility fractures, costs, and readmission rates, as well as 2-year implant complications were compared between cohorts. A total of 50,328 zolpidem patients were matched to 251,286 hypnotic naive patients. RESULTS: The zolpidem group had significantly higher rates of medical complications, falls, and fragility fractures when compared to the hypnotic-naive group. The zolpidem group had significantly higher rates of dislocation, mechanical loosening, and periprosthetic fracture. Likewise, healthcare utilization was significantly greater in the zolpidem group. CONCLUSION: Zolpidem use following THA is associated with significant risk of medical and implant complications, as well as fall risks, increased costs, lengths of stay, and readmissions. The findings of this study may affect discussions between orthopaedic surgeons and their patients on the benefits of sleep quality in their recovery versus the incurred risks of zolpidem use. LEVEL OF EVIDENCE: III, retrospective case-control study.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Mekkawy KL, Rodriguez HC, Gosthe RG, et al. Immediate Postoperative Zolpidem Use Increases Risk of Falls and Implant Complication Rates Following Total Hip Arthroplasty: A Retrospective Case-Control Analysis. J Arthroplasty. 2023. PMID: 37562745. doi:10.1016/j.arth.2023.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。